Delayed-release glucocorticoid treatment of rheumatoid disease
AssigneeHZNP Limited
InventorAchim Schaeffler
Life of this patent
Estimating the term…
Abstract
The present invention refers to the treatment of a rheumatic disease and/or osteoarthritis by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
Claims20
-79. (canceled)
A method for the treatment of a patient suffering from signs and symptoms of an underlying rheumatic disease and/or osteoarthritis, which comprises administering to said patient an effective amount of prednisone contained in a delayed-release dosage form,
- wherein said treatment is administered once daily for at least about two weeks,
- wherein said treatment with said prednisone contained in a delayed-release dosage form provides an increased reduction in the duration of morning stiffness as compared to treatment with prednisone in an immediate release dosage form, and
- wherein the delayed release dosage form is a tablet or a capsule.
A method for the treatment of a patient suffering from signs and symptoms of an underlying rheumatic disease and/or osteoarthritis, which comprises administering to said patient an effective amount of prednisone contained in a delayed-release dosage form,
- wherein said treatment is administered once daily for at least about two weeks,
- wherein said patient has previously undergone treatment with a disease-modifying antirheumatic drugs (DMARD), and
- wherein the delayed release dosage form is a tablet or a capsule.
Dependencies are inferred from the claim text.